According to a large-scale European study, systemic medications commonly used to manage diabetes and levels of blood lipids can lower the prevalence of age-related macular degeneration (AMD) in the population, highlighting the connection between AMD and cardiovascular morbidities.

A total of 38,694 adults from 14 population- and hospital-based studies were...